Oncology CT

The number of CT scans corresponds to an increase in risk of hematologic malignant neoplasms, especially in children under age 16.

An early analysis shows that low-dose CT screening for lung cancer has still not fully rebounded, leading to later detection of cancers.

Low-dose CT screening for lung cancer does present risks of false-positives and over-diagnosis, but for heavy or ex-smokers, it is worth it.

DECT and electron density offers more accurate differentiation between metastatic and non-metastatic lymph nodes when compared to FDG PET/CT.

Low-dose CT for lung cancer screening offers significant benefits for detection and follow-up, but utilization, to date, has been low. Debra S. Dyer, M.D., chair of the American College of Radiology's Lung Cancer Screening 2.0 Committee discusses what the screening provides and the challenges to more widespread implementation.

Here's what to expect this week on Diagnostic Imaging.

Third annual report from the American Lung Association reveals 94 percent of high-risk eligible patients are not getting screening with LDCT, and access and outcomes are worse for racial and ethnic minorities.

Rapid COVID-19 Diagnosis with CT and CO-RADS; Cooled Radiofrequency Ablation for Pain Relief; Inappropriate Abdominal CT and Ultrasound Scans; and Lead Shielding Guidance

States with higher lung cancer burden have lower low-dose CT lung cancer screening rates.

Diagnostic Imaging and Testicular Cancer Risk; Digital Breast Tomosynthesis/Synthetic Mammography Combination for Breast Cancer Screening; Efficacy of Low-Dose CT Lung Cancer Screening; and the Evolving Role of the Radiologic Technologist

Even potential for over-diagnosis does not appear to increase other causes of mortality.

Cerebral Aneurysms and CT Angiography; MammoScreen and Breast Cancer Detection; Low-Dose Lung Cancer Screening Program Performance; and Breast Cancer Screening Advocacy Efforts

In a study from China, there was no statistical significance in cancer detection rates between high-risk patients who were screened and those who were not.

Here's what to expect this week on Diagnostic Imaging.

Breast Cancer Screening in Indian & Pakistani Women; Fluciclovine PET for Prostate Cancer Imaging; Cardiac Ultrasound & COVID-19; and Improving Mammography Patient Experience

Research indicates patients who undergo a single 28-Gy session experience similar outcomes to those who have four 12-Gy sessions, pointing to safer, faster treatment.

18F-fluciclovine PET/MRI can improve treatment guidance with better staging and evaluation of androgen deprivation therapy.

African American, as well as other racial and ethnic minority, patients likely have lower levels of CTC screening due to out-of-pocket costs.

What to expect this week on Diagnostic Imaging.

Pulmonary artery thrombosis presents differently from acute pulmonary embolism on CT scans.

Results indicate radiologic findings are better survival predictors than pathologic vessel invasion.

Dropping National Lung Cancer Screening radiation dose by two-thirds can yield images of diagnostic quality of solid lung nodules.

Men in this patient group are less likely to have a PET scan with the radiotracer that performs the best.

PET/MRI vs. PET/CT; Abdominal CT and COVID-19; Chest MRI vs Chest CT; Expert Interpretations of Endometriosis; and Delayed Breast Cancer Treatments for African American Women

CEUS is a safer, less expensive option for diagnosing focal liver disease.

Azurion Lung Edition is supports precision diagnosis and minimally invasive therapy in one room.

Treatment does not significantly change three-year disease-free survival rates.

States with expanded coverage saw an increase in cancer diagnosis for covered adults, as well as the overall population.

PET/MRI detects more lesions with less radiation, making it a great option for pediatric patients.

Rethinking CMR during COVID-19; Abdominal Imaging and COVID-19; Mental Health Impacts of COVID-19; African American and Lung Cancer Screening; Plus, African American Women and Disadvantages in Breast Cancer Screening